These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 590467)

  • 1. Differences in cytochalasin D-induced surface alterations between chronic lymphocytic leukaemic and normal lymphocytes.
    Skinnider L
    Experientia; 1977 Dec; 33(12):1652-3. PubMed ID: 590467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochalasins distinguish by their action resting human T lymphocytes from activated T-cell blasts.
    Otteskog P; Wanger L; Sundqvist KG
    Exp Cell Res; 1983 Apr; 144(2):443-54. PubMed ID: 6601583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the behavior of the membrane and membrane-associated filamentous structures in normal and chronic lymphocytic leukemia (CLL) lymphocytes.
    Zucker-Franklin D; Liebes LF; Silber R
    J Immunol; 1979 Jan; 122(1):97-107. PubMed ID: 762427
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of cytochalasins on lymphocytes: some distinctive features of cytochalasin-E.
    Mookerjee BK; Jung CY
    J Immunopharmacol; 1984; 6(3):185-203. PubMed ID: 6491312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cytochalasins on lymphocytes: mechanism of inhibition of rosette formation.
    Mookerjee BK; Jung CY
    J Immunol; 1983 Sep; 131(3):1126-30. PubMed ID: 6684138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochalasin B is a potent mitogen for chronic lymphocytic leukemia cells in vitro.
    Larson RA; Yachnin S
    J Clin Invest; 1983 Oct; 72(4):1268-76. PubMed ID: 6630510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural comparison of the cell coat in normal and chronic lymphocytic leukaemic blood lymphocytes by Concanavalin A labelling and cationic staining.
    Calman F
    Pathol Eur; 1975; 10(3):203-14. PubMed ID: 52860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface structure of normal and leukaemic lymphocytes. I. Effect of mitogens.
    Holt PJ; Pal SG; Catovsky D; Lewis SM
    Clin Exp Immunol; 1972 Apr; 10(4):555-70. PubMed ID: 5034244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lymphocyte surface immunoglobulin capping. Normal characteristics and anomalous behavior of chronic lymphocytic leukemic lymphocytes.
    Cohen HJ
    J Clin Invest; 1975 Jan; 55(1):84-93. PubMed ID: 1088910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane cycling and macrovacuolation under the influence of cytochalasin: kinetic and morphometric studies.
    Brett JG; Godman GC
    Tissue Cell; 1984; 16(3):325-35. PubMed ID: 6087496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cortisol on the ultrastructure of normal, leukemic, and cultured human lymphocytes.
    Werthamer S; Amaral L
    In Vitro; 1975; 11(4):212-23. PubMed ID: 1176157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal ultrastructural changes in sodium periodate-stimulated lymphocytes from patients with chronic lymphocytic leukemia.
    McGill M; Monahan TM; Novak RA; Abell CW
    Cancer Res; 1976 Dec; 36(12):4513-9. PubMed ID: 187326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane permeability in normal human lymphocytes and lymphocytes from patients with chronic lymphatic leukaemia.
    Hallak GJ; Wilkinson JH
    Clin Chim Acta; 1976 Jun; 69(2):341-9. PubMed ID: 1277564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemia.
    Fernandez LA; MacSween JM; Langley GR
    Immunology; 1975 Feb; 28(2):231-41. PubMed ID: 1091543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between effects of 24 different cytochalasins on cellular structures and cellular events and those on actin in vitro.
    Yahara I; Harada F; Sekita S; Yoshihira K; Natori S
    J Cell Biol; 1982 Jan; 92(1):69-78. PubMed ID: 7199054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered function and membrane properties of lymphocytic leukemia cells. Correlation with clinical stage of disease.
    Prokocimer M; Polliack A; Rosenkovitch E; Ben-Bassat H
    Isr J Med Sci; 1982 Jul; 18(7):746-52. PubMed ID: 7107217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell membrane markers in acute lymphoid leukemia in relapse.
    De Rossi G; Guglielmi C; Pasqualetti D; Lopez M; Mandelli F
    Biomedicine; 1981 Oct; 35(5):156-8. PubMed ID: 6947827
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic lymphoproliferative disorder with unusual clinical, morphologic, ultrastructural and membrane surface marker characteristics.
    McKenna RW; Parkin J; Kersey JH; Gajl-Peczalska KJ; Peterson L; Brunning RD
    Am J Med; 1977 Apr; 62(4):588-96. PubMed ID: 192076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic lymphocytic leukemia lymphocytes: membrane anomalies and H2O2 vulnerability.
    Silber R; Stahl RL; Farber CM; Kanganis D; Astrow A; Liebes LF
    Blood Cells; 1984; 10(2-3):233-9. PubMed ID: 6336165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SEM observation of cultured, mitogen-stimulated leukocytes. Cells obtained from patients with acute myeloblastic and chronic lymphocytic leukemias.
    Lalague ED; Abugaber AA; Haviernick S; Corvellec MR; Pelletier L; Derghazarian C; Cousineau GH
    Experientia; 1982 Jan; 38(1):90-2. PubMed ID: 6948687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.